A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

• Autors principals: Qian H (Autor), Chen Q (Autor), Liang L (Autor), Zou Y (Autor), Pu H (Autor), Xin L (Autor), Song R (Autor), Li T (Autor), Zhu H (Autor), Wang Y (Autor), Tian G (Autor), Shen J (Autor), Jiang H (Autor), Yu C (Autor), Wang Z (Autor), Jia J (Autor)
• Format: Llibre
• Publicat: Dove Medical Press, 2021-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Hongjie Qian,1,2 Qian Chen,1,2 Liyu Liang,1,2 Yang Zou,1,2 Huahua Pu,1,2 Liang Xin,1,2 Rong Song,1,2 Tingting Li,1,2 Huijuan Zhu,1,2 Yu Wang,3 Guanghui Tian,4 Jingshan Shen,2,3 Hualiang Jiang,2,3 Chen Yu,1,2 Zhen Wang,2,3 Jingying Jia1,2 1Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai...